Pheon Therapeutics

Pheon Therapeutics is an antibody-drug conjugate (ADC) specialist developing a pipeline of therapies for hard-to-treat solid tumors. The company utilizes monoclonal antibodies against both novel and clinically validated targets, pairing them with proprietary payloads or off-the-shelf linker combinations. Its primary focus is transitioning its lead asset into clinical development while building a follow-on pipeline to address unmet medical needs across multiple cancer types.